mutat
ubiquitin
ligas
parkin
common
known
caus
autosom
recess
parkinson
multipl
type
stress
decreas
parkin
protein
level
effect
may
relev
sporad
parkinson
diseas
pd
mechan
involv
loss
remain
larg
unclear
sought
elucid
mechan
use
pdrelev
stressor
ldopa
precursor
dopamin
form
reactiv
oxygen
speci
ro
well
toxic
quinon
via
autooxid
find
ldopa
caus
parkin
loss
oxid
stressindepend
oxid
stressdepend
pathway
character
latter
reveal
requir
kinas
parkin
interact
phosphoryl
ubiquitin
phosphoub
mediat
proteasom
degrad
surprisingli
mitochondri
parkin
activ
autoubiquitin
well
mitophagi
requir
loss
stress
induc
oxid
stressor
hydrogen
peroxid
metabol
uncoupl
cccp
parkin
degrad
also
requir
associ
phosphoub
indic
mechan
broadli
generaliz
oxid
stress
metabol
dysfunct
phosphoub
level
elev
pd
patient
suggest
chang
may
lead
loss
parkin
express
pd
parkinson
diseas
pd
debilit
neurodegen
disord
affect
roughli
age
though
case
pd
appear
sporad
minor
case
clear
autosom
domin
recess
inherit
pattern
common
known
caus
autosom
recess
pd
homozyg
inactiv
encod
ubiquitin
ligas
parkin
parkin
demonstr
promot
cell
surviv
mani
differ
context
also
evid
parkin
loss
may
play
role
pathogenesi
sporad
pd
strategi
aim
upregul
parkin
level
maintain
activ
state
hold
therapeut
promis
sporad
pd
though
much
work
examin
function
parkin
recent
mechan
activ
phosphoubiquitin
phosphoub
phosphoryl
substanti
less
known
level
total
activ
parkin
regul
cell
import
insight
parkin
regul
come
vitro
vivo
observ
divers
stressor
caus
decreas
parkin
protein
level
stressor
includ
mitochondri
complex
inhibitor
oxid
agent
dnadamag
agent
mitochondri
dysfunct
oxid
stress
wellcharacter
aspect
pd
suggest
parkin
loss
stress
may
occur
possibl
contribut
progress
disord
howev
mechan
involv
parkin
loss
stressor
larg
unclear
addit
mitochondri
depolar
also
shown
caus
parkin
loss
loss
gener
thought
link
process
parkinmedi
mitophagi
though
one
studi
suggest
parkin
autoubiquitin
lead
degrad
prevent
mitophagi
follow
mitochondri
depolar
degre
parkin
loss
mitochondri
depolar
align
mechanist
parkin
loss
stressor
uncertain
one
possibl
contributor
common
mitochondri
kinas
parkin
associ
phosphoub
gener
stressor
also
lead
parkin
degrad
suggest
mechan
broadlygeneraliz
surprisingli
find
parkin
loss
downstream
associ
phosphoub
appear
requir
canon
mitochondri
parkin
activ
mitophagi
assess
effect
ldopa
cellular
level
parkin
treat
neuron
differenti
cell
variou
concentr
ldopa
hour
determin
rel
parkin
express
western
immunoblot
wb
cell
catecholaminerg
produc
princip
da
wide
use
investig
catecholamin
function
metabol
well
model
studi
potenti
caus
treatment
pd
neuron
differenti
cell
also
possess
level
parkin
easili
detect
wb
make
fit
model
evalu
effect
stress
endogen
parkin
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
next
ask
whether
decreas
product
andor
increas
degrad
respons
parkin
loss
ldopa
treatment
observ
signific
decreas
parkin
mrna
level
ldopa
treatment
rel
mrna
level
ldopa
treatment
respect
contrast
effect
ldopa
halflif
protein
fig
find
suggest
loss
parkin
occur
ldopa
due
least
part
enhanc
degrad
ldopa
promot
parkin
loss
least
part
increas
turnov
would
expect
see
loss
overexpress
exogen
parkin
initi
studi
observ
consist
specif
ldopapromot
loss
highli
overexpress
exogen
parkin
driven
promot
fig
suggest
high
level
parkin
abl
overwhelm
ldopainduc
parkin
degrad
mechan
contrast
moder
overexpress
nterminallytag
parkin
use
minim
human
parkin
promot
lead
overexpress
endogen
parkin
level
observ
ldopainduc
loss
exogen
parkin
similar
observ
endogen
protein
exogen
parkin
loss
ldopa
p
n
fig
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ldopainduc
oxid
stress
contribut
parkin
loss
given
ldopa
shown
caus
oxid
stress
cultur
cell
examin
whether
ldopainduc
oxid
stress
play
role
parkin
loss
treat
differenti
cell
ldopa
presenc
antioxid
glutathion
glutathion
gsh
significantli
attenu
parkin
loss
ldopa
rescu
complet
loss
ldopa
alon
vs
loss
ldopa
gsh
n
p
p
ldopa
gsh
vs
gsh
alon
n
fig
observ
enhanc
protect
parkin
ldopainduc
loss
use
higher
dose
glutathion
pretreat
cell
glutathion
prior
ldopa
exposur
fig
result
indic
oxid
stress
least
partial
respons
ldopainduc
parkin
loss
nonoxid
mechan
may
account
half
loss
ldopa
gener
reactiv
oxygen
speci
ro
via
nonenzymat
autoxid
convers
dopamin
subsequ
autoxid
oxid
metabol
latter
test
whether
convers
ldopa
dopamin
requir
effect
parkin
use
carbidopa
block
activ
aromat
lamino
acid
decarboxylas
aadc
enzym
respons
convers
anticip
ldopa
treatment
alon
hour
significantli
increas
intracellular
dopamin
level
fold
control
level
p
n
fig
cotreat
carbidopa
robustli
diminish
effect
fold
control
level
p
vs
ldopa
alon
n
impact
loss
parkin
ldopa
treatment
parkin
loss
ldopa
alon
vs
loss
ldopa
carbidopa
p
n
fig
result
suggest
autoxid
ldopa
rather
convers
dopamin
sourc
oxid
stress
lead
parkin
loss
follow
ldopa
treatment
system
consist
possibl
observ
brown
cell
cultur
medium
hour
exposur
ldopa
even
absenc
cell
fig
shown
result
quinon
format
ldopa
autoxid
confirm
oxid
stress
capabl
induc
parkin
loss
treat
cell
hydrogen
peroxid
observ
reduct
parkin
protein
compar
found
ldopa
p
vs
untreat
control
n
fig
line
previou
report
altogeth
result
indic
oxid
stress
ldopa
autoxid
significantli
contribut
ldopainduc
parkin
loss
kinas
report
play
role
parkin
turnov
includ
caus
hydrogen
peroxid
exposur
therefor
examin
whether
involv
ldopadepend
parkin
loss
knock
differenti
cell
use
previouslycharacter
shrna
knockdown
effect
mrna
level
reduc
transcript
level
control
level
day
p
n
fig
knockdown
significantli
attenu
ldopainduc
parkin
loss
half
achiev
ldopa
alon
parkin
loss
shctrl
vs
loss
p
shctrl
ldopa
vs
ldopa
n
fig
find
indic
inde
involv
ldopamedi
parkin
loss
mechan
also
appear
contribut
process
promot
turnov
cellular
protein
must
activ
role
kinas
parkin
turnov
respons
ldopa
thu
suggest
latter
caus
activ
assess
examin
ubiquitin
phosphoub
readout
activ
baselin
phosphoub
present
low
undetect
level
cell
follow
mitochondri
depolar
becom
stabil
outer
mitochondri
membran
activ
lead
phosphoryl
ubiquitin
result
accumul
phosphoryl
polyubiquitin
chain
phosphopolyub
detect
western
blot
expect
observ
littl
phosphoub
untreat
cell
fig
posit
control
activ
phosphoub
induct
treat
cell
protonophor
carbonyl
cyanid
cccp
wide
use
mitochondri
depolar
agent
follow
cccp
treatement
observ
appear
high
molecular
weight
phosphoub
ladder
consist
format
phosphopolyub
chain
fig
treatment
cell
ldopa
also
led
format
phosphopolyub
fig
although
strength
ldopainduc
phosphopolyub
signal
time
weaker
induc
cccp
p
n
ldopa
cccp
fig
observ
format
unconjug
monophosphoub
ldopa
treatment
fig
knockdown
strongli
attenu
phosphopolyub
signal
cccp
exposur
shctrl
p
n
caus
similar
downward
trend
ldopainduc
phosphopolyub
signal
shctrl
p
n
indic
inde
appear
involv
gener
signal
fig
f
togeth
result
indic
ldopa
exposur
lead
activ
albeit
lesser
extent
cccp
exposur
activ
contribut
parkin
loss
associ
ldopainduc
phosphoub
lead
parkin
loss
implic
ldopainduc
parkin
deplet
next
sought
uncov
mechan
contribut
loss
activ
parkin
phosphoryl
parkin
ubiquitin
parkin
bind
latter
noncoval
parkin
bind
unconjug
phosphomonoub
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
phosphopolyub
chain
reason
parkin
phosphoryl
parkin
bind
ldopainduc
phosphoub
event
may
underli
parkin
loss
determin
rel
import
event
introduc
sever
point
mutat
moder
overexpress
exogen
parkin
construct
describ
fig
test
import
parkin
phosphoryl
gener
parkin
mutant
test
import
phosphoub
bind
parkin
gener
parkin
mutant
latter
mutat
significantli
abrog
interact
parkin
phosphoub
although
demonstr
effect
regard
deliv
parkin
mutant
cell
via
lentivir
transduct
test
respons
ldopa
treatment
although
viral
titer
construct
vari
slightli
due
inher
variabl
viral
product
process
found
parkin
mutant
use
studi
express
similar
level
ie
higher
endogen
parkin
cell
control
titer
fig
ldopa
induc
signific
loss
wildtyp
overexpress
parkin
hour
treatment
expect
loss
p
n
fig
b
howev
mutant
defici
bind
phosphoub
significantli
resist
loss
compar
wildtyp
parkin
loss
n
p
vs
wt
ldopa
loss
n
p
vs
wt
ldopa
fig
b
note
degre
protect
ldopainduc
loss
afford
mutat
similar
degre
protect
afford
knockdown
fig
suggest
contribut
ldopamedi
parkin
loss
may
fulli
account
parkin
interact
phosphoub
agreement
parkin
mutant
protect
ldopainduc
loss
compar
wildtyp
parkin
loss
n
p
fig
b
indic
parkin
phosphoryl
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
requir
parkin
loss
also
test
whether
protect
effect
might
reveal
context
parkin
mutant
defici
bind
phosphoub
howev
observ
greater
protect
ldopa
doubl
mutant
singl
mutant
loss
n
p
vs
alon
fig
b
find
indic
parkin
interact
phosphoub
requir
portion
loss
follow
ldopa
treatment
parkin
phosphoryl
appear
dispens
howev
one
potenti
reserv
interpret
mutant
parkin
construct
ntermin
tag
differenti
endogen
parkin
tag
report
disrupt
parkin
autoinhibit
conform
open
ubl
domain
parkin
phosphoryl
also
report
open
ubl
domain
wish
ensur
effect
parkin
phosphoryl
made
function
redund
presenc
tag
took
advantag
find
parkin
phosphoryl
requir
full
parkin
activ
respons
cccp
compar
level
cccpinduc
phosphopolyub
cell
transduc
either
wildtyp
parkin
reason
sinc
parkin
phosphoryl
contribut
activ
sinc
activ
lead
phosphopolyub
format
follow
mitochondri
depolar
would
expect
see
decreas
level
phosphopolyub
cccp
suggest
parkin
loss
ldopa
treatment
occur
via
two
distinct
pathway
oxid
stress
activ
play
role
one
pathway
determin
whether
oxid
stressdepend
glutathionesensit
phosphoubdepend
mechan
parkin
loss
pathway
investig
whether
glutathion
abrog
phosphoub
signal
induc
ldopa
given
major
signal
present
high
molecular
weight
phosphopolyub
conjug
examin
effect
glutathion
phosphopolyub
found
glutathion
prevent
ldopainduc
phosphopolyub
format
almost
complet
treatment
phosphopolyub
rel
ldopa
treatment
p
n
ldopa
gsh
rel
ldopa
treatment
p
n
fig
addit
hydrogen
peroxid
exposur
induc
phosphopolyub
format
fig
result
indic
oxid
stress
ldopa
exposur
lead
activ
turn
lead
format
phosphoub
associ
parkin
parkin
loss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
place
portion
parkin
loss
ldopa
pathway
ldopainduc
format
phosphoub
next
ask
whether
extent
parkin
interact
phosphoub
play
role
loss
stressor
given
hydrogen
peroxid
caus
parkin
loss
fig
induc
phosphopolyub
format
fig
first
queri
whether
parkin
loss
oxid
stressor
also
mediat
interact
phosphoub
achiev
util
neuron
cell
moder
overexpress
either
wildtyp
variou
mutant
form
parkin
inde
wildtyp
parkin
level
decreas
half
upon
peroxid
treatment
parkin
remain
p
n
parkin
mutant
nearli
complet
rescu
loss
induc
agent
peroxid
parkin
remain
n
p
vs
treatment
peroxid
parkin
remain
n
p
vs
treatment
fig
e
ldopa
model
observ
protect
peroxideinduc
loss
mutant
parkin
remain
n
p
vs
wt
fig
base
result
appear
parkin
associ
phosphoub
critic
fulli
account
degrad
follow
exposur
hydrogen
peroxid
next
examin
whether
parkin
associ
phosphoub
also
central
loss
mitochondri
depolar
agent
cccp
mitochondri
depolar
shown
caus
parkin
loss
manner
anticip
cccp
led
signific
loss
wildtyp
overexpress
parkin
hour
treatment
parkin
loss
n
n
hour
respect
p
time
point
fig
b
contrast
parkin
mutant
fulli
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
vs
treatment
fig
hour
remain
fulli
protect
parkin
remain
n
p
vs
treatment
show
loss
n
p
vs
treatment
fig
like
explan
discrep
behavior
parkin
mutant
hour
shown
greater
residu
phosphoub
bind
ldopa
hydrogen
peroxid
model
parkin
mutant
protect
cccp
compar
wildtyp
parkin
n
vs
wt
n
remain
hour
p
n
vs
wt
n
remain
hour
p
observ
protect
doubl
mutant
singl
mutant
hour
cccp
treatment
n
vs
n
remain
p
fig
b
altogeth
data
indic
phosphoub
gener
divers
stressor
induc
parkin
degrad
phosphopolyub
present
cytosol
mitochondri
fraction
lead
mitochondri
parkin
transloc
given
import
phosphoub
parkin
loss
oxid
stress
mitochondri
depolar
next
queri
cell
phosphoub
found
examin
high
molecular
weight
phosphopolyub
domin
speci
phosphoub
observ
previou
work
shown
phosphopolyub
present
cytosol
mitochondria
follow
activ
mitochondri
depolar
line
find
subcellular
fraction
reveal
similar
amount
phosphopoli
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
given
substanti
presenc
phosphopolyub
mitochondri
fraction
ldopa
treatment
affin
parkin
phosphoub
predict
would
observ
mitochondri
parkin
transloc
follow
ldopa
treatment
analog
observ
follow
cccp
exposur
agreement
saw
modest
signific
increas
parkin
mitochondri
fraction
hour
ldopa
treatment
ldopa
vs
without
p
n
fig
e
time
ldopainduc
parkin
loss
complet
fig
posit
control
examin
mitochondri
transloc
parkin
follow
hour
cccp
exposur
time
parkin
loss
underway
complet
fig
similarli
effect
ldopa
treatment
increas
parkin
mitochondri
fraction
cccp
treatment
cccp
vs
without
p
n
fig
f
altogeth
result
suggest
parkin
associ
stressinduc
phosphopolyub
cytosol
mitochondria
degrad
next
sought
address
mechan
parkin
degrad
follow
associ
phosphoub
two
previou
studi
report
parkin
degrad
proteasom
mitochondri
depolar
agreement
report
proteasom
inhibitor
epoxomicin
fulli
abrog
cccpinduc
parkin
loss
cccp
untreat
cccp
epoxomicin
untreat
p
n
fig
significantli
also
abrog
ldopainduc
parkin
loss
half
ldopa
untreat
ldopa
epoxomicin
untreat
p
n
consist
half
ldopainduc
parkin
loss
phosphoubdepend
fig
lysosom
activ
caspas
cleavag
report
degrad
parkin
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
inhibit
pathway
abrog
parkin
loss
ldopa
treatment
ldopa
parkin
loss
ldopa
bafilomycin
parkin
loss
p
n
ldopa
parkin
loss
ldopa
zvadfmk
parkin
loss
p
n
fig
b
taken
togeth
data
indic
phosphoubdepend
parkin
degrad
mediat
proteasom
variou
model
test
ldopa
appear
affect
parkin
solubl
addit
degrad
mechan
variou
stressor
also
report
diminish
avail
parkin
level
disrupt
structur
decreas
solubl
assess
whether
might
contribut
appar
parkin
loss
ldopa
exposur
harvest
ldopatr
nontreat
cell
either
standard
lysi
buffer
strong
lysi
buffer
contain
urea
addit
lithium
dodecyl
sulfat
ld
strong
lysi
buffer
produc
significantli
higher
yield
parkin
recoveri
standard
lysi
buffer
parkin
loss
urea
buffer
parkin
loss
p
n
fig
find
suggest
ldopa
reduc
appar
cellular
level
parkin
reduc
solubl
phosphoubdepend
parkin
loss
requir
canon
mitochondri
parkin
activ
mitophagi
initi
parkin
particip
posit
feedback
loop
wherein
parkinmedi
polyubiquitin
mitochondri
protein
provid
ubiquitin
substrat
phosphoryl
gener
phosphopolyub
accord
process
parkin
activ
found
increas
total
amount
cellular
phosphoub
follow
mitochondri
depolar
process
occur
model
would
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
expect
stressinduc
phosphopolyub
format
phosphoubinduc
parkin
loss
depend
parkin
ligas
activ
examin
possibl
compar
level
stressinduc
phosphopolyub
cell
transduc
moder
overexpress
wildtyp
parkin
catalyt
inact
parkin
mutant
empti
control
vector
cccptreat
cell
express
wildtyp
parkin
increas
phosphopolyub
signal
cell
express
empti
vector
anticip
wt
rel
empti
vector
p
n
fig
b
increas
phosphopolyub
signal
attribut
parkin
activ
catalyt
inact
parkin
almost
complet
abrog
increas
phosphopoli
lack
evid
parkindepend
phosphopolyub
format
follow
ldopa
hydrogen
peroxid
treatment
suggest
mitochondri
parkin
activ
necessari
phosphopolyubdepend
loss
inde
ldopa
exposur
decreas
catalyt
inact
parkin
level
extent
wildtyp
parkin
wt
loss
n
loss
n
p
fig
f
contrast
parkin
protect
cccpinduc
loss
hour
hr
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
wt
loss
loss
p
n
hr
wt
loss
loss
p
n
fig
c
consist
diminish
phosphopolyub
signal
observ
cell
rel
cell
express
exogen
wildtyp
parkin
case
hydrogen
peroxid
modestli
protect
peroxideinduc
loss
wt
loss
loss
p
n
effect
less
robust
seen
cccp
result
indic
extent
parkinmedi
phosphopolyub
format
play
role
parkin
loss
depend
natur
initi
stress
lack
evid
phosphopolyub
format
exogen
parkin
follow
ldopa
treatment
suggest
endogen
parkin
similarli
contribut
format
chain
ldopa
model
examin
possibl
mitochondri
phosphopolyub
assess
ubiquitin
mitochondri
gtpase
follow
ldopa
treatment
recent
studi
show
prefer
mitochondri
parkin
substrat
mitophagi
provid
evid
polyubiquitin
parkin
preced
may
requir
parkin
effici
ubiquitin
mitochondri
substrat
primaci
ubiquitin
coupl
find
polyubiquitin
chain
mitochondri
protein
phosphoryl
gener
mitochondri
phosphopolyub
make
ubiquitin
use
proxi
contribut
endogen
parkin
mitochondri
phosphopolyub
format
first
assess
ubiquitin
follow
cccp
treatment
reveal
rapid
polyubiquitin
ultim
loss
former
loss
hour
rel
time
zero
p
vs
treatment
n
fig
b
contrast
observ
ubiquitin
loss
hour
ldopa
treatment
despit
robust
parkin
loss
remain
hour
rel
time
zero
p
vs
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
treatment
n
fig
fig
result
line
find
use
overexpress
parkin
indic
phosphoubdepend
degrad
endogen
parkin
requir
parkin
canon
mitochondri
polyubiquitin
activ
phosphoubdepend
parkin
loss
requir
parkin
autoubiquitin
note
given
parkin
shown
autoubiquitin
ci
find
parkin
protect
ldopainduc
deplet
indic
loss
due
autoubiquitin
parkin
autoubiquitin
report
follow
mitochondri
depolar
reflect
format
highermolecular
weight
parkin
speci
detect
wb
previous
suggest
autoubiquitin
target
parkin
proteasom
degrad
follow
mitochondri
depolar
studi
parkin
autobiquitin
observ
ubiquitin
parkin
signal
gener
strongest
band
correspond
monoubiquitin
parkin
multiplyubiquitin
parkin
speci
also
detect
though
diminish
intens
extend
observ
parkin
treat
cell
either
ldopa
cccp
presenc
absenc
epoxomicin
carri
western
blot
detect
highermolecular
weight
parkin
form
fig
b
case
detect
highermolecular
weight
parkin
band
consist
idea
autoubiquitin
requir
parkin
loss
phosphoubdepend
parkin
loss
requir
mitophagi
lack
ubiquitin
loss
upon
ldopa
treatment
suggest
ldopa
induc
parkinmedi
mitophagi
determin
whether
case
assess
level
mitochondri
protein
ldopa
treatment
mitophagi
lead
gradual
decreas
mitochondri
protein
compart
detect
wb
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
howev
observ
ubiquitin
signific
loss
mitochondri
protein
evalu
includ
vdac
omm
omm
imm
immmatrix
hour
ldopa
treatment
fig
confirm
efficaci
ldopa
treatment
experi
assess
parkin
level
observ
anticip
decreas
loss
hour
rel
time
zero
p
vs
treatment
n
fig
addit
assess
level
long
isoform
mitochondri
gtpase
cleav
respons
mitochondri
stress
ldopa
treatment
induc
loss
isoform
decreas
hour
rel
time
zero
p
vs
treatment
n
fig
consist
promot
mitochondri
stress
taken
togeth
data
indic
presenc
mitochondri
stress
lack
robust
mitophagi
ldopa
model
given
parkin
clearli
activ
cell
cccp
treatment
fig
b
fig
b
also
sought
determin
whether
activ
led
mitophagi
cccptreat
cell
examin
protein
ldopa
treatment
observ
ubiquitin
loss
consist
mitophagi
cell
expos
cccp
fig
level
decreas
cccp
decreas
hour
rel
time
zero
p
vs
treatment
n
vdac
remain
unchang
fig
ldopa
treatment
parkin
loss
still
robust
experi
loss
hour
p
vs
treatment
n
fig
level
long
isoform
drop
precipit
respons
mitochondri
membran
potenti
loss
decreas
hour
rel
time
zero
p
vs
treatment
n
fig
result
indic
even
parkin
clearli
activ
polyubiquitin
mitophagi
may
necessarili
take
place
consist
previou
report
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
altogeth
data
indic
phosphoubmedi
parkin
degrad
requir
canon
mitochondri
parkin
activ
mitophagi
studi
investig
mechan
stressor
ldopa
particular
decreas
cellular
level
parkin
protein
found
ldopa
caus
parkin
loss
via
two
distinct
pathway
oxid
stressdepend
pathway
driven
ldopa
autoxid
oxid
stressindepend
pathway
respons
half
parkin
loss
fig
conclud
oxid
stress
play
role
one
pathway
parkin
mutant
defici
bind
phosphoub
partli
protect
ldopainduc
loss
wherea
fulli
protect
loss
induc
oxid
stressor
hydrogen
peroxid
furthermor
exposur
antioxid
glutathion
critic
neuron
defens
ro
attenu
ldopainduc
parkin
loss
half
although
glutathion
lack
membran
permeabl
react
effici
kind
ro
glutathion
treatment
previous
shown
effect
complet
prevent
autoxid
ldopa
dopamin
analog
respect
quinon
addit
glutathion
treatment
found
complet
prevent
cell
death
induc
ldopa
dopamin
hydrogen
peroxid
oxid
nitric
oxid
support
glutathion
capac
prevent
ldopainduc
oxid
stress
hand
observ
almost
complet
abrog
ldopainduc
phosphopolyub
format
upon
glutathion
treatment
nevertheless
possibl
aspect
ldopainduc
oxid
stress
fulli
neutral
glutathion
model
would
led
us
underestim
contribut
oxid
stress
parkin
loss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
oxid
stress
welldocu
pd
focus
oxid
stressdepend
pathway
parkin
loss
found
pathway
oxid
stress
lead
ubiquitin
phosphoryl
mostli
high
molecular
weight
polyub
conjug
furthermor
found
parkin
associ
phosphoub
induc
variou
stressor
lead
proteasom
degrad
autoubiquitin
surprisingli
phosphoubinduc
parkin
degrad
appear
requir
parkin
mitochondri
activ
experi
parkin
point
mutant
reveal
parkin
bind
stressinduc
phosphoub
critic
loss
parkin
phosphoryl
per
se
dispens
find
parkin
protect
loss
induc
stressor
use
unexpect
phosphoryl
increas
bind
affin
parkin
phosphoub
given
import
phosphoub
bind
parkin
loss
anticip
parkin
would
exhibit
greater
protect
stressinduc
degrad
due
lower
affin
phosphoub
contrari
wildtyp
parkin
equal
deplet
condit
studi
though
rule
possibl
wildtyp
parkin
lost
rapidli
respons
stress
mutant
import
question
work
rais
parkin
bind
phosphoub
follow
cellular
stress
lead
loss
one
possibl
conform
chang
parkin
occur
upon
bind
phosphoub
make
vulner
degrad
case
conform
chang
must
specif
phosphoub
bind
induc
parkin
phosphoryl
show
phosphoub
bind
import
parkin
loss
event
propos
releas
parkin
ubl
domain
interact
domain
also
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
shown
facilit
access
ubiquitinconjug
enzym
parkin
bind
site
accordingli
neither
effect
like
crucial
conform
chang
involv
parkin
degrad
instead
conform
chang
may
promot
parkin
loss
movement
ibr
domain
away
ubl
domain
movement
thu
far
attribut
phosphoub
bind
rais
plausibl
candid
trigger
parkin
loss
altern
instead
induc
critic
conform
chang
parkin
associ
phosphoub
may
caus
parkin
loss
bring
proxim
protein
promot
degrad
find
proteasom
mediat
parkin
degrad
downstream
associ
phosphoub
line
prior
work
report
proteasom
parkin
degrad
follow
mitochondri
depolar
overexpress
addit
result
support
find
other
parkin
degrad
proteasom
latter
addit
studi
suggest
proteasom
parkin
degrad
mediat
autoubiquitin
possibl
directli
test
observ
catalyt
inact
parkin
protect
ldopainduc
loss
indic
parkin
proteasom
degrad
downstream
stressinduc
phosphoub
bind
due
autoubiquitin
occur
ci
find
contrari
model
propos
explain
depolarizationinduc
parkin
loss
consist
find
parkin
autoubiquitin
appear
protect
degrad
addit
find
interest
phosphoubdepend
parkin
degrad
appear
requir
parkin
mitochondri
polyubiquitin
activ
sinc
polyubiquitin
loss
occur
respons
ldopa
despit
robust
parkin
loss
sinc
parkin
overexpress
increas
phosphopolyub
format
unexpect
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
parkin
particip
wellestablish
posit
feedback
loop
reli
activ
enzym
gener
phosphopolyub
mitophagi
initi
result
therefor
indic
parkin
may
associ
phosphoryl
polyub
chain
gener
anotheroth
ligas
also
observ
treatment
ldopa
cccp
promot
parkin
loss
caus
loss
mitochondri
protein
consist
robust
induct
mitophagi
result
therefor
indic
mitophagi
requir
phosphoubdepend
parkin
degrad
find
inconsist
suggest
parkin
degrad
downstream
mitochondri
depolar
link
mitochondri
elimin
instead
result
indic
parkin
associ
phosphoub
key
determin
depolarizationand
oxidativestressinduc
loss
loss
occur
independ
mitophagi
line
previou
studi
import
implic
find
phosphoub
involv
parkin
loss
parkin
activ
phosphoub
appear
intim
link
parkin
degrad
observ
phenomenon
across
differ
model
cellular
stress
suggest
broadli
generaliz
therefor
possibl
degrad
cellular
mechan
activ
parkin
turn
recent
studi
found
phosphoub
level
elev
substantia
nigra
patient
lewi
bodi
diseas
categori
includ
pd
given
find
observ
suggest
parkin
level
may
lower
patient
due
enhanc
phosphoubinduc
turnov
decreas
could
turn
contribut
pd
patholog
find
way
uncoupl
parkin
associ
phosphoub
degrad
may
attract
therapeut
avenu
pd
treatment
differenti
cell
undifferenti
cell
one
dish
first
resuspend
rpmi
hors
serum
penicillinstreptomycin
cell
pass
repeat
pipettor
tip
dispers
count
use
hemacytomet
plate
densiti
cellsml
plate
rpmi
hors
serum
penicillinstreptomycin
ngml
human
recombin
ngf
kind
gift
genentech
gemini
bioproduct
remain
undifferenti
cell
plate
freshlyco
cm
dish
cell
use
experi
day
differenti
experi
lentivir
transduct
cell
transduc
day
differenti
shrna
construct
cell
treat
drug
day
transduct
overexpress
construct
cell
treat
drug
day
transduct
differenti
undifferenti
cell
half
medium
replac
everi
day
fresh
medium
cell
kept
incub
cortic
neuron
grown
plate
coat
polydlysin
millipor
sigma
mgml
polydlysin
ad
multiwel
plate
plate
left
cover
cell
cultur
incub
overnight
follow
day
polydlysin
solut
aspir
well
wash
least
three
time
steril
deioniz
water
well
allow
dri
cell
plate
day
cortic
harvest
rat
embryon
brain
cold
hbss
without
calcium
chlorid
magnesium
chlorid
magnesium
sulfat
thermo
fisher
scientif
use
dissect
microscop
cortic
dissoci
incub
trypsin
subsequ
tritur
hbss
two
firepolish
pasteur
pipett
decreas
apertur
size
neuron
pass
cell
strainer
count
plate
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
cellsml
polydlysineco
plate
neurobas
medium
supplement
supplement
thermo
fisher
scientif
mm
glutamax
thermo
fisher
scientif
penicillinstreptomycin
half
medium
replac
fresh
medium
twice
week
cell
kept
incub
cell
use
experi
day
vitro
human
neuroblastoma
cell
kind
gift
dr
ismael
santamaria
perez
grown
medium
cellgro
supplement
fb
mm
glutamin
penicillinstreptomycin
immort
mef
kind
gift
dr
thong
un
kang
lab
columbia
univers
isol
immort
cell
describ
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
tag
parkin
minim
parkin
promot
two
step
involv
gener
moder
overexpress
parkin
construct
first
rat
parkin
cdna
amplifi
previous
gener
parkin
construct
describ
use
primer
attach
haand
flagtag
nterminu
primer
use
f
ctagcctcgaggtttaaacatgtacccatacgatgttccagattacgctgcagcaaatgatatc
ctggattacaaggatgacgacgataagctcccgcggacgcgtacgatagtgtttgtcagg
r
tgcagcccgtagtttaaacctacacgtcaaaccagtgatc
amplifi
ntag
cdna
insert
pwpi
vector
addgen
linear
pmei
restrict
site
infus
clone
clontech
use
purpos
accord
manufactur
instruct
second
step
promot
pwpihaflagparkin
construct
cut
ppumi
paci
site
minim
human
parkin
promot
amplifi
commerci
avail
luciferas
construct
switchgear
genom
insert
place
use
hifi
dna
assembl
kit
new
england
biolab
sitedirect
mutagenesi
moder
overexpress
parkin
carri
use
sitedirect
mutagenesi
kit
new
england
biolab
accord
manufactur
instruct
earli
passag
cell
plate
densiti
x
plate
next
day
cell
transfect
express
vector
vsvg
plasmid
per
plate
use
calcium
phosphat
transfect
method
viruscontain
medium
harvest
day
transfect
pool
pass
filter
wv
hydrogen
peroxid
dilut
steril
distil
water
subsequ
dilut
fresh
medium
cccp
dissolv
dmso
yield
mm
stock
solut
filtersteril
ad
fresh
medium
addit
cell
stock
solut
store
use
multipl
time
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
inhibitor
antioxid
dissolv
water
possibl
dmso
watersolubl
case
stock
solut
drug
dilut
fresh
medium
addit
cell
except
cycloheximid
case
fresh
medium
ad
cell
day
treatment
cycloheximid
stock
solut
ad
directli
cell
case
drug
cellular
stressor
ldopa
cccp
ad
cell
time
case
carbidopa
cycloheximid
latter
ad
cell
treatment
ldopa
cell
pretreat
carbidopa
hour
cycloheximid
minut
ldopa
addit
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
precast
bistri
gel
mop
sd
run
buffer
me
sd
run
buffer
low
molecular
weight
protein
nupag
transfer
buffer
gener
gel
use
protein
ad
per
well
one
sampl
per
gel
half
sampl
ad
well
adjac
full
volum
sampl
serv
standard
see
protein
transfer
onto
nitrocellulos
membran
hour
follow
transfer
membran
block
hour
room
temperatur
gentl
shake
milk
tbst
tb
tween
membran
probe
primari
antibodi
dilut
tbst
bsa
overnight
next
day
membran
subject
fiveminut
wash
tbst
incub
hour
room
temperatur
licor
irdy
secondari
antibodi
bsatbst
dark
wash
three
time
follow
incub
secondari
antibodi
membran
kept
tb
dark
membran
imag
use
licor
odyssey
clx
scanner
band
intens
quantifi
use
imag
studio
lite
softwar
ver
briefli
background
subtract
signal
lane
half
volum
sampl
load
assign
valu
use
concentr
standard
featur
similarli
signal
lane
correspond
full
volum
sampl
assign
valu
program
linear
interpol
featur
use
assign
valu
remain
band
blot
process
carri
protein
interest
load
control
former
normal
latter
experi
band
interest
normal
averag
correspond
signal
though
sometim
ponceau
stain
also
use
load
control
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
prepar
crude
mitochondri
cytosol
fraction
cell
follow
protocol
follow
cell
lysat
kept
ice
durat
procedur
centrifug
step
perform
first
cell
spray
dish
pb
pellet
centrifug
cell
four
well
plate
combin
one
tube
analysi
mrna
qpcr
perform
briefli
total
cellular
rna
extract
use
tri
reagent
molecular
research
center
cdna
synthes
use
firststrand
cdna
synthesi
kit
origen
qpcr
perform
use
faststart
sybr
green
master
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
immunofluoresc
quantif
viral
titer
cell
fix
min
paraformaldehyd
wash
time
pb
cell
block
superblock
block
buffer
supplement
triton
h
room
temperatur
incub
overnight
primari
antibodi
superblocktriton
x
chicken
antigfp
thermo
fisher
scientif
gentl
shake
next
day
primari
antibodi
wash
wash
gentl
shake
use
pb
cell
incub
fluoresc
secondari
antibodi
superblocktriton
x
hour
gentl
shake
antichicken
thermo
fisher
scientif
cell
wash
x
minut
pb
gentl
shake
hoechst
ad
first
wash
cell
kept
pb
imag
use
invert
fluoresc
microscop
cell
death
assess
previous
describ
briefli
cell
treat
lysi
buffer
lysi
buffer
per
cm
disintegr
plasma
membran
keep
nuclei
intact
count
viabl
nuclei
manual
use
hemacytomet
least
nuclei
count
per
condit
lysi
buffer
recip
g
cetyldimethylethanolammonium
bromid
g
nacl
ml
glacial
acet
acid
ml
triton
ml
ml
pb
ml
statist
analysi
perform
use
graphpad
prism
use
onlin
multipl
comparison
correct
resourc
http
alexandercoppockcomstatisticalcomparisonshtml
develop
alexand
coppock
describ
experi
valu
normal
control
condit
experi
replic
experi
combin
pair
ttest
perform
case
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
follow
holm
correct
multipl
comparison
timecours
analys
unpair
ttest
time
point
follow
holmsidak
multipl
comparison
test
use
analysi
differ
parkin
mutant
oneway
anova
stressortr
mutant
perform
follow
holmsidak
correct
multipl
comparison
differenti
cell
transduc
day
lentivir
vector
carri
indic
parkin
mutant
bicistron
express
gfp
cell
harvest
western
immunoblot
repres
blot
shown
compar
rel
express
level
differ
parkin
mutant
parkin
level
construct
normal
first
control
load
differ
gfp
control
variabl
viral
titer
result
quantif
shown
right
error
bar
show
sem
independ
experi
p
rel
wt
pair
ttest
holm
correct
multipl
comparison
figur
associ
phosphoub
lead
parkin
loss
cccp
treatment
b
differenti
cell
transduc
lentivir
vector
carri
indic
parkin
mutant
three
five
day
infect
cell
treat
cccp
b
hour
harvest
western
immunoblot
assess
parkin
protein
level
repres
immunoblot
quantif
parkin
level
shown
level
parkin
mutant
cccp
treatment
normal
level
mutant
control
treatment
set
case
latter
repres
leftmost
gray
bar
quantif
error
bar
show
sem
n
b
independ
experi
p
p
rel
wt
oneway
anova
cccptreat
mutant
holmsidak
multipl
comparison
test
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
mitophagi
requir
phosphoubdepend
parkin
degrad
b
ldopa
cccp
induc
chang
mitochondri
protein
level
consist
robust
mitophagi
differenti
cell
treat
ldopa
cccp
b
indic
time
harvest
wb
repres
blot
quantif
indic
protein
n
independ
experi
shown
ldopa
significantli
decreas
level
vdac
induc
loss
parkin
b
cccp
significantli
decreas
level
vdac
induc
loss
parkin
error
bar
show
sem
p
unpair
ttest
holmsidak
correct
multipl
comparison
signific
queri
untreat
drugtreat
group
time
point
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
model
ldopainduc
parkin
loss
ldopa
decreas
parkin
via
two
pathway
oxid
stressdepend
independ
mechan
latter
pathway
remain
unclear
former
pathway
result
ldopa
autoxid
induc
stabil
mitochondri
outer
membran
phosphoryl
polyubiquitin
chain
cytosol
mitochondria
though
unclear
substrat
protein
polyubiquitin
chain
conjug
indic
singl
question
mark
model
parkin
associ
phosphopolyub
chain
build
ubiquitin
chain
mitochondri
protein
follow
associ
phosphopolyub
parkin
degrad
via
proteasom
independ
autoubiquitin
mitophagi
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
